What are the diagnostic criteria and treatment options for rheumatoid arthritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosing Rheumatoid Arthritis

Use the 2010 ACR/EULAR Classification Criteria, which requires a score of ≥6/10 points based on joint involvement, serology, acute phase reactants, and symptom duration to diagnose rheumatoid arthritis. 1

Target Population for Testing

  • Apply diagnostic criteria only to patients with at least one joint showing definite clinical synovitis (swelling) that is not better explained by another disease. 1, 2
  • Symmetric involvement of small joints—particularly metacarpophalangeal (MCP) joints, proximal interphalangeal (PIP) joints, wrists, and metatarsophalangeal (MTP) joints—is characteristic of RA. 3
  • Large joints (shoulders, elbows, hips, knees, ankles) may also be affected, but distal interphalangeal joints, first carpometacarpal joints, and first MTP joints are typically spared. 3

The 2010 ACR/EULAR Scoring System

A score of ≥6/10 points is required for definite RA classification. 1 Calculate the score by adding points from four categories:

A) Joint Involvement (0-5 points)

  • 1 large joint = 0 points 1
  • 2-10 large joints = 1 point 1
  • 1-3 small joints (with or without large joint involvement) = 2 points 1
  • 4-10 small joints (with or without large joint involvement) = 3 points 1
  • 10 joints, including at least 1 small joint = 5 points 1

B) Serology (0-3 points)

  • Negative RF and negative ACPA = 0 points 1
  • Low positive RF or low positive ACPA = 2 points 1
  • High positive RF or high positive ACPA = 3 points 1

Critical caveat: Seronegative RA accounts for 20-30% of cases, so negative RF does not exclude RA. 3, 4 Do not delay treatment waiting for positive serology—seronegative RA has a similar prognosis to seropositive disease. 3, 4

C) Acute Phase Reactants (0-1 point)

  • Normal CRP and normal ESR = 0 points 1
  • Abnormal CRP or abnormal ESR = 1 point 1

Use CRP rather than ESR because it is more reliable, simpler, and not age-dependent. 1 However, acute phase reactants can be normal even in active disease, so do not dismiss the diagnosis based on normal inflammatory markers. 3

D) Duration of Symptoms (0-1 point)

  • <6 weeks = 0 points 1
  • ≥6 weeks = 1 point 1

Essential Clinical Examination

Perform a 28-joint count assessment examining for tenderness and swelling in: 1, 3

  • PIPs (1st through 5th bilaterally)
  • MCPs (1st through 5th bilaterally)
  • Wrists
  • Elbows
  • Shoulders
  • Knees

Squeeze test of MCPs and MTPs helps assess for clinical synovitis. 3

Look for early-morning stiffness lasting ≥1 hour and difficulty making a fist. 3, 4

Laboratory Workup

Initial Testing

  • ACPA (anti-citrullinated protein antibody): High specificity (90%) with moderate sensitivity (60%) 3
  • Rheumatoid factor (RF): Lower specificity (70%) with similar sensitivity to ACPA 3
  • CRP (preferred over ESR) 1
  • Complete blood count with differential 3, 5
  • Comprehensive metabolic panel (liver function, renal function, glucose, urate) 3
  • Urinalysis 3

Additional Testing When Diagnosis is Uncertain

  • ANA to screen for other connective tissue diseases 3
  • HLA-B27 if spondyloarthropathy is being considered 3

Pre-Treatment Screening (Before Biologics)

  • Hepatitis B, Hepatitis C, and tuberculosis screening are required before starting any biologic therapy. 3, 5

Imaging Studies

Baseline Imaging

Obtain bilateral hand, wrist, and foot X-rays at baseline to detect erosions and monitor structural damage progression. 3, 4

Conventional radiography findings include: 3

  • Periarticular osteopenia
  • Uniform joint space narrowing
  • Osseous erosions

Erosions predict RA diagnosis and disease persistence. 3

Advanced Imaging (When Criteria Not Met)

  • Ultrasound is superior to clinical examination for detecting inflammation and structural damage, and can detect synovitis that predicts disease progression. 3
  • Power Doppler ultrasound is useful when patients with early arthritis do not meet the 2010 ACR/EULAR criteria. 3
  • MRI with IV contrast is more sensitive than ultrasound in early stages, detecting bone marrow edema (osteitis), which is the best single predictor of future disease progression and functional deterioration. 3

Clinical Examples

Example of early RA diagnosis: A patient with early-morning stiffness, a swollen wrist joint, and strongly positive ACPA test results for 6 weeks (or less with an abnormal CRP) fulfills the criteria for RA, and disease-modifying therapy should be initiated. 1

Differential Diagnoses to Exclude

Before diagnosing RA, exclude: 1, 3, 4

  • Psoriatic arthritis
  • Gout (check uric acid level)
  • Hemochromatosis
  • Systemic lupus erythematosus
  • Spondyloarthropathies
  • Crystal arthropathies
  • Polymyalgia rheumatica
  • Still's disease

Urgent Referral Strategy

Patients with suspected early RA should be seen within 1-2 weeks of referral through "early arthritis clinics" or urgent appointment slots. 1 Early diagnosis allows for earlier treatment with disease-modifying antirheumatic drugs, which is associated with better outcomes. 2, 5

Disease Activity Assessment After Diagnosis

Once RA is diagnosed, quantitative assessment of disease activity is essential using composite measures: 1, 3

  • DAS28 (Disease Activity Score using 28 joint counts) 3
  • SDAI (Simplified Disease Activity Index): Remission ≤3.3, low disease activity ≤11 3, 4
  • CDAI (Clinical Disease Activity Index): Remission ≤2.8, low disease activity ≤10 3

Include patient-reported outcomes: 1

  • Pain assessment
  • Patient Global Assessment of Disease Activity
  • Health Assessment Questionnaire Disability Index

The primary target of treatment is remission or low disease activity. 3, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Rheumatoid Arthritis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Differentiating Reactive Arthritis from Rheumatoid Arthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and management of rheumatoid arthritis.

American family physician, 2011

Guideline

EULAR Criteria and Treatment Recommendations for Rheumatoid Arthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.